{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:34:22Z","timestamp":1786984462637,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["15K19121"],"award-info":[{"award-number":["15K19121"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["22114004"],"award-info":[{"award-number":["22114004"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H24-006"],"award-info":[{"award-number":["H24-006"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["17fk0310104h0001"],"award-info":[{"award-number":["17fk0310104h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.antiviral.2017.06.005","type":"journal-article","created":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T04:17:14Z","timestamp":1497586634000},"page":"138-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Identification of KX2-391 as an inhibitor of HBV transcription by a recombinant HBV-based screening assay"],"prefix":"10.1016","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9726-8470","authenticated-orcid":false,"given":"Keisuke","family":"Harada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Nishitsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saneyuki","family":"Ujino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunitada","family":"Shimotohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2017.06.005_bib1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10549-011-1513-3","article-title":"KX-01, a novel Src kinase inhibitor directed toward the peptide substrate site, synergizes with tamoxifen in estrogen receptor \u03b1 positive breast cancer","volume":"132","author":"Anbalagan","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.antiviral.2017.06.005_bib2","doi-asserted-by":"crossref","DOI":"10.1007\/s00280-013-2079-z","article-title":"A\u00a0phase 2 study of KX2-391, an oral inhibitor of Src kinase and tubulin polymerization, in men with bone-metastatic castration-resistant prostate cancer","author":"Antonarakis","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.antiviral.2017.06.005_bib3","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1126\/science.294.5550.2376","article-title":"Calcium signaling by HBx protein in hepatitis B virus DNA replication","volume":"294","author":"Bouchard","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2017.06.005_bib4","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1016\/j.ejmech.2011.07.050","article-title":"Thiazolyl N-benzyl-substituted acetamide derivatives: synthesis, Src kinase inhibitory and anticancer activities","volume":"46","author":"Fallah-Tafti","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.antiviral.2017.06.005_bib5","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.1128\/JVI.74.11.5032-5039.2000","article-title":"The hepatitis B virus core promoter is strongly activated by the liver nuclear receptor fetoprotein transcription factor or by ectopically expressed steroidogenic factor 1","volume":"74","author":"Gilbert","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.06.005_bib6","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1128\/JVI.79.5.2729-2742.2005","article-title":"Identification and characterization of avihepadnaviruses isolated from exotic anseriformes maintained in captivity","volume":"79","author":"Guo","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.06.005_bib7","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.ajpath.2015.01.028","article-title":"Novel robust in\u00a0vitro hepatitis B virus infection model using fresh human hepatocytes isolated from humanized mice","volume":"185","author":"Ishida","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.antiviral.2017.06.005_bib8","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1124\/mol.115.099341","article-title":"Pregnane X receptor represses HNF4alpha gene to induce insulin-like growth factor-binding protein IGFBP1 that alters morphology of and migrates HepG2 cells","volume":"88","author":"Kodama","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.antiviral.2017.06.005_bib9","doi-asserted-by":"crossref","DOI":"10.1046\/j.1365-2893.2002.00381.x","article-title":"Regulatory elements of hepatitis B virus transcription","author":"Moolla","year":"2002","journal-title":"J.\u00a0Viral Hepat."},{"key":"10.1016\/j.antiviral.2017.06.005_bib10","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s10637-013-9929-8","article-title":"A\u00a0phase I trial of KX2-391, a novel non-ATP competitive substrate-pocket- directed SRC inhibitor, in patients with advanced malignancies","volume":"31","author":"Naing","year":"2013","journal-title":"Incest. New. Drugs"},{"key":"10.1016\/j.antiviral.2017.06.005_bib11","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1124\/dmd.31.5.681","article-title":"Induction of cytochrome P450 3a by paclitaxel in mice: pivotal role of the nuclear xenobiotic receptor, pregnane X receptor","volume":"31","author":"Nallani","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.antiviral.2017.06.005_bib12","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/cas.12799","article-title":"Novel reporter system to monitor early stages of the hepatitis B virus life cycle","volume":"106","author":"Nishitsuji","year":"2015","journal-title":"Cancer Sci."},{"key":"10.1016\/j.antiviral.2017.06.005_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2893.2010.01315.x","article-title":"Control of hepatitis B virus at the level of transcription","author":"Quasdorff","year":"2010","journal-title":"J.\u00a0Viral Hepat."},{"key":"10.1016\/j.antiviral.2017.06.005_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2006.10.007","article-title":"Occult hepatitis B virus infection","author":"Raimondo","year":"2007","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.antiviral.2017.06.005_bib15","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1128\/JVI.02303-05","article-title":"Lipid-mediated introduction of hepatitis B virus capsids into nonsusceptible cells allows highly efficient replication and facilitates the study of early infection events","volume":"80","author":"Rabe","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.06.005_bib16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1124\/pr.54.1.129","article-title":"Liver-enriched transcription factors in liver function and development. Part I: the hepatocyte nuclear factor network and liver-specific gene expression","volume":"54","author":"Schrem","year":"2002","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.antiviral.2017.06.005_bib17","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/hep.21896","article-title":"Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans","volume":"46","author":"Schulze","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2017.06.005_bib18","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1345\/aph.1P354","article-title":"Induction of CYP3A4 by vinblastine: role of the nuclear receptor NR1I2","volume":"44","author":"Smith","year":"2010","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.antiviral.2017.06.005_bib19","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/hep.21345","article-title":"Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens","volume":"44","author":"Sugiyama","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2017.06.005_bib20","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","article-title":"Hepatitis B virus infection","volume":"384","author":"Trepo","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2017.06.005_bib21","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.23163","article-title":"Identification of androgen response elements in the enhancer I of hepatitis B virus: a mechanism for sex disparity in chronic hepatitis B","volume":"50","author":"Wang","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2017.06.005_bib22","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.antiviral.2015.06.007","article-title":"Irbesartan, an FDA approved drug for hypertension and diabetic nephropathy, is a potent inhibitor for hepatitis B virus entry by disturbing Na(+)-dependent taurocholate cotransporting polypeptide activity","volume":"120","author":"Wang","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.06.005_bib23","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1002\/hep.26982","article-title":"Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP)","volume":"59","author":"Watashi","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2017.06.005_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001143","article-title":"Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription","volume":"2","author":"Wu","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2017.06.005_bib25","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v21.i5.1498","article-title":"S-phase arrest after vincristine treatment may promote hepatitis B virus replication","author":"Xu","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2017.06.005_bib26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/095632020201300302","article-title":"Sulphated and sulphonated polymers inhibit the initial interaction of hepatitis B virus with hepatocytes","volume":"13","author":"Ying","year":"2002","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.antiviral.2017.06.005_bib27","doi-asserted-by":"crossref","first-page":"9366","DOI":"10.1128\/jvi.71.12.9366-9374.1997","article-title":"Differential regulation of the pre-C and pregenomic promoters of human hepatitis B virus by members of the nuclear receptor superfamily","volume":"71","author":"Yu","year":"1997","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.06.005_bib28","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1128\/JVI.77.4.2489-2499.2003","article-title":"Distinct modes of regulation of transcription of hepatitis B virus by the nuclear receptors HNF4 {alpha} and COUP-TF1","volume":"77","author":"Yu","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.06.005_bib29","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1473-3099(01)00118-9","article-title":"Treatment of chronic hepatitis B","volume":"1","author":"Yuen","year":"2001","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.06.005_bib30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A\u00a0simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J.\u00a0Biomol. Screen"},{"key":"10.1016\/j.antiviral.2017.06.005_bib31","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.antiviral.2006.05.006","article-title":"Hepatitis B virus e antigen production is dependent upon covalently closed circular (ccc) DNA in HepAD38 cell cultures and may serve as a cccDNA surrogate in antiviral screening assays","volume":"72","author":"Zhou","year":"2006","journal-title":"Antivir. Res."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216307276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216307276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T01:51:00Z","timestamp":1656208260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216307276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":31,"alternative-id":["S0166354216307276"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.06.005","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of KX2-391 as an inhibitor of HBV transcription by a recombinant HBV-based screening assay","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}